Chung Wu Investment Group »

Dianthus Therapeutics shares owned by Chung Wu Investment Group

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Chung Wu Investment Group from 13F filings

Historical chart of Chung Wu Investment Group investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Chung Wu Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Chung Wu Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $193k 2.3k 83.92

More positions owned by Chung Wu Investment Group

Ishares Tr Core S&p500 Etf Core S&p500 Etf (IVV)
Neos S&p 500 High Income Etf Neos S&p 500 Hi (SPYI)
State Street Spdr Dow Jones Industrial Average Etf Ut Ser 1 (DIA)
Neos Nasdaq 100 High Income Etf Nasdaq 100 High (QQQI)
Microsoft Corporation (MSFT)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Eaton Vance Enhanced Equity Incm. Fd. II (EOS)
NVIDIA Corporation (NVDA)
Antero Midstream Corp antero midstream (AM)
Exxon Mobil Corporation (XOM)
State Street Spdr S&p 500 Etf Trust Tr Unit (SPY)
MasTec (MTZ)
Ge Vernova (GEV)

View all positions for Chung Wu Investment Group

Top funds holding Dianthus Therapeutics

FMR
BlackRock
RA Capital Management
Fairmount Funds Management
Wellington Management Company
Avidity Partners Management
Vanguard Group
Vanguard Capital Management
Octagon Capital Advisors
TCG Crossover Management
Citadel Advisors
State Street Corporation
VR Adviser
Fred Alger Management
Deerfield Management Company

View all funds holding Dianthus Therapeutics